title: 2013 statement on human papillomavirus [corrected] test utilization.
abstract: This statement from the Cytopathology Education and Technology Consortium summarizes appropriate and inappropriate uses of human papillomavirus testing in cervical cancer screening based on guidelines from the American Society for Colposcopy and Cervical Pathology and the American Cancer Society. © 2014 S. Karger AG, Basel.
authors: Department of Clinical Sciences, University of Central Florida College of Medicine and Orlando Veterans Affairs Medical Center, Orlando, Fla., USA.
authors: Diane
authors: D
authors: Davis Davey
authors: Robert
authors: R
authors: Goulart
authors: Ritu
authors: R
authors: Nayar
mesh_terms: D000328:Adult; D004279:DNA, Viral / Q000235:genetics*; D005260:Female; D061809:Human Papillomavirus DNA Tests / Q000379:methods* / Q000592:standards / Q000706:statistics & numerical data*; D006801:Humans; D008403:Mass Screening / Q000379:methods; D027383:Papillomaviridae / Q000235:genetics*; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000821:virology*; D017410:Practice Guidelines as Topic; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000821:virology*; D055815:Young Adult
chemical_list: D004279:DNA, Viral